21st Century Therapeutics

21st Century Therapeutics

Biotechnology, Seven Oaks Dr, Utica, , 48316, Michigan, 52673, United States, 1-10 Employees

21centurythr.com

  • LinkedIn

phone no Phone Number: +12*********

Who is 21ST CENTURY THERAPEUTICS

21st Century Therapeutics Inc is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform that integrates cutting-edge gene e...

Read More

map
  • 52673 Seven Oaks Dr, Utica, Michigan, 48316, United States Headquarters: 52673 Seven Oaks Dr, Utica, Michigan, 48316, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 8071 | NAICS Code: 621511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from 21ST CENTURY THERAPEUTICS

21st Century Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding 21st Century Therapeutics

Answer: 21st Century Therapeutics's headquarters are located at Seven Oaks Dr, Utica, , 48316, Michigan, 52673, United States

Answer: 21st Century Therapeutics's phone number is +12*********

Answer: 21st Century Therapeutics's official website is https://21centurythr.com

Answer: 21st Century Therapeutics's revenue is $1 Million to $5 Million

Answer: 21st Century Therapeutics's SIC: 8071

Answer: 21st Century Therapeutics's NAICS: 621511

Answer: 21st Century Therapeutics has 1-10 employees

Answer: 21st Century Therapeutics is in Biotechnology

Answer: 21st Century Therapeutics contact info: Phone number: +12********* Website: https://21centurythr.com

Answer: 21st Century Therapeutics Inc is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical need.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access